{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:56:43Z","timestamp":1781708203676,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T00:00:00Z","timestamp":1682035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01PS005140"],"award-info":[{"award-number":["U01PS005140"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["U01PS005140"],"award-info":[{"award-number":["U01PS005140"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Expanding pre-exposure prophylaxis (PrEP) among transgender women in the United States is an important strategy to meet national HIV prevention goals, however self-reported use of PrEP is low in this group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study reports the findings of a cross-sectional analysis of the relationship of barriers as well as facilitators to recent PrEP use among transgender women enrolled in an evaluation of the TransLife Care project (Chicago, Illinois), a structural intervention designed to meet basic needs. We computed multivariable prevalence ratios for barriers, facilitators and recent PrEP use, controlling for demographics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Findings suggest that psychosocial and structural barriers, including moderate\/high alcohol use, stimulant use, and history of incarceration were all positively associated with recent PrEP use among urban transgender women. In addition, a psychosocial facilitator, gender affirmation, was positively associated with recent PrEP use, while, while collective self-esteem, a was negatively associated with it. Finally, common indications for PrEP have high sensitivity, but low specificity and predictive value for identifying those on PrEP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We conclude that despite a large gap in PrEP use among those with indications, individuals experiencing psychosocial and structural barriers are more likely to use PrEP, and facilitators, such as psychological sense of affirmed gender may support its use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>N\/A.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12981-023-00516-0","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T17:02:27Z","timestamp":1682096547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A cross-sectional analysis of psychosocial and structural barriers and facilitators associated with PrEP use among a sample of transgender women in Chicago, IL"],"prefix":"10.1186","volume":"20","author":[{"given":"Lisa M.","family":"Kuhns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Perloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie Lynne","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Pleasant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiji","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian J.","family":"Denson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Gelaude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Bessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Diskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marbella","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Hotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,21]]},"reference":[{"key":"516_CR1","unstructured":"Centers for Disease Control and Prevention. HIV infection, risk, prevention, and testing behaviors among transgender women - national HIV behavioral surveillance, 7 U.S. cities, 2019\u20132020. http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html; 2021 April."},{"issue":"9","key":"516_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343]","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV Epidemic: a plan for the United States. JAMA. 2019;321(9):844\u20135. https:\/\/doi.org\/10.1001\/jama.2019.1343]. [PMID 30730529].","journal-title":"JAMA"},{"issue":"7","key":"516_CR3","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1007\/s10461-015","volume":"20","author":"LM Kuhns","year":"2016","unstructured":"Kuhns LM, Reisner SL, Mimiaga MJ, Gayles T, Shelendich M, Garofalo R. Correlates of PrEP indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women. AIDS Behav. 2016;20(7):1470\u20137. https:\/\/doi.org\/10.1007\/s10461-015-1182-z. 1182-z] [PMID 26336946].","journal-title":"AIDS Behav"},{"key":"516_CR4","doi-asserted-by":"publisher","first-page":"101998doi","DOI":"10.1016\/j.evalprogplan.2021.101998]","volume":"90","author":"KC Parrish","year":"2022","unstructured":"Parrish KC, Johnson HZ, Williams SL. PrEP navigation continuum among men who have sex with men, trans women, and people with alternative gender identities in three California counties. Eval Program Plann. 2022;90:101998doi. https:\/\/doi.org\/10.1016\/j.evalprogplan.2021.101998]. [PMID 34544606].","journal-title":"Eval Program Plann"},{"issue":"1","key":"516_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/qai.0000000000002726]","volume":"88","author":"J Malone","year":"2021","unstructured":"Malone J, Reisner SL, Cooney EE, Poteat T, Cannon CM, Schneider JS, et al. Perceived HIV Acquisition Risk and Low Uptake of PrEP among a cohort of Transgender Women with PrEP indication in the Eastern and Southern United States. J Acquir Immune Defic Syndr. 2021;88(1):10\u20138. https:\/\/doi.org\/10.1097\/qai.0000000000002726]. [PMID 34397742].","journal-title":"J Acquir Immune Defic Syndr"},{"key":"516_CR6","volume-title":"Preexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2021 update: a clinical practice guideline","author":"Centers for Disease Control and Prevention","year":"2021","unstructured":"Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States \u2013 2021 update: a clinical practice guideline. www.cdc.gov: US Public Health Service; 2021."},{"issue":"7","key":"516_CR7","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10461-021-03159-2]","volume":"25","author":"A Ogunbajo","year":"2021","unstructured":"Ogunbajo A, Storholm ED, Ober AJ, Bogart LM, Reback CJ, Flynn R, et al. Multilevel barriers to HIV PrEP Uptake and Adherence among Black and Hispanic\/Latinx Transgender Women in Southern California. AIDS Behav. 2021;25(7):2301\u201315. https:\/\/doi.org\/10.1007\/s10461-021-03159-2]. [PMID 33515132].","journal-title":"AIDS Behav"},{"issue":"2","key":"516_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/09540121.2020.1769835]","volume":"33","author":"O Nieto","year":"2021","unstructured":"Nieto O, Fehrenbacher AE, Cabral A, Landrian A, Brooks RA. Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users. AIDS Care. 2021;33(2):244\u201352. https:\/\/doi.org\/10.1080\/09540121.2020.1769835]. [PMID 32449399].","journal-title":"AIDS Care"},{"issue":"Suppl 6","key":"516_CR9","doi-asserted-by":"publisher","first-page":"21105doi","DOI":"10.7448\/ias.19.7.21105","volume":"19","author":"JM Sevelius","year":"2016","unstructured":"Sevelius JM, Deutsch MB, Grant R. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. J Int AIDS Soc. 2016;19(Suppl 6):21105doi. https:\/\/doi.org\/10.7448\/ias.19.7.21105. 21105] [PMID 27760683].","journal-title":"J Int AIDS Soc"},{"issue":"7\u20138","key":"516_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1080\/17441692.2016.1154085]","volume":"11","author":"JM Sevelius","year":"2016","unstructured":"Sevelius JM, Keatley J, Calma N, Arnold E. I am not a man\u2019: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Glob Public Health. 2016;11(7\u20138):1060\u201375. https:\/\/doi.org\/10.1080\/17441692.2016.1154085]. [PMID 26963756].","journal-title":"Glob Public Health"},{"key":"516_CR11","doi-asserted-by":"publisher","unstructured":"Sevelius JM, Chakravarty D, Dilworth SE, Rebchook G, Neilands TB. Measuring satisfaction and comfort with gender identity and gender expression among Transgender Women: Development and Validation of the psychological gender affirmation Scale. Int J Environ Res Public Health. 2021;18(6). https:\/\/doi.org\/10.3390\/ijerph18063298]. [PMID 33806834].","DOI":"10.3390\/ijerph18063298]"},{"issue":"4","key":"516_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1521\/aeap.2021.33.4.345]","volume":"33","author":"SD Rhodes","year":"2021","unstructured":"Rhodes SD, Kuhns LM, Alexander J, Alonzo J, Bessler PA, Courtenay-Quirk C, et al. Evaluating locally developed Interventions to promote PrEP among Racially\/Ethnically diverse Transgender Women in the United States: a unique CDC Initiative. AIDS Educ Prev. 2021;33(4):345\u201360. https:\/\/doi.org\/10.1521\/aeap.2021.33.4.345]. [PMID 34370565].","journal-title":"AIDS Educ Prev"},{"issue":"2","key":"516_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0749-3797(18)30622-6","volume":"10","author":"EM Andresen","year":"1994","unstructured":"Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (center for epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77\u201384. [doi [PMID 8037935].","journal-title":"Am J Prev Med"},{"issue":"10","key":"516_CR14","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092]","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092. https:\/\/doi.org\/10.1001\/archinte.166.10.1092]. [PMID 16717171].","journal-title":"Arch Intern Med"},{"issue":"3","key":"516_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1037\/h0080345","volume":"68","author":"AR D\u2019Augelli","year":"1998","unstructured":"D\u2019Augelli AR, Hershberger SL, Pilkington NW. Lesbian, gay, and bisexual youth and their families: disclosure of sexual orientation and its consequences. Am J Orthopsychiatry. 1998;68(3):361\u201371. discussion 72 \u2013 5.[doi 10.1037\/h0080345] [PMID 9686289].","journal-title":"Am J Orthopsychiatry"},{"issue":"10","key":"516_CR16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/jamapediatrics.2018.1799]","volume":"172","author":"R Garofalo","year":"2018","unstructured":"Garofalo R, Kuhns LM, Reisner SL, Biello K, Mimiaga MJ. Efficacy of an Empowerment-Based, Group-Delivered HIV Prevention intervention for Young Transgender Women: the Project LifeSkills Randomized Clinical Trial. JAMA Pediatr. 2018;172(10):916\u201323. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.1799]. [PMID 30105381].","journal-title":"JAMA Pediatr"},{"issue":"11\u201312","key":"516_CR17","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11199-012-0216-5]","volume":"68","author":"JM Sevelius","year":"2013","unstructured":"Sevelius JM. Gender affirmation: a Framework for conceptualizing risk behavior among Transgender Women of Color. Sex Roles. 2013;68(11\u201312):675\u201389. https:\/\/doi.org\/10.1007\/s11199-012-0216-5]. [PMID 23729971].","journal-title":"Sex Roles"},{"key":"516_CR18","doi-asserted-by":"crossref","unstructured":"Crocker J, JLuhtanen R. Collective self-esteem and ingroup bias.Journal of Personality & Social Psychology. 1990;58:60 \u2013 7.[doi [PMID","DOI":"10.1037\/0022-3514.58.1.60"},{"key":"516_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/qai.0000000000002915]","author":"L Starbuck","year":"2022","unstructured":"Starbuck L, Golub SA, Klein A, Harris AB, Guerra A, Rincon C, et al. Transgender Women and PrEP Care: high PrEP adherence in a Real-World Health Care setting in New York City. J Acquir Immune Defic Syndr. 2022. https:\/\/doi.org\/10.1097\/qai.0000000000002915]. [PMID 35013087].","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"516_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/qai.0000000000002403]","volume":"84","author":"JM Sevelius","year":"2020","unstructured":"Sevelius JM, Poteat T, Luhur WE, Reisner SL, Meyer IH. HIV Testing and PrEP Use in a National Probability Sample of sexually active Transgender People in the United States. J Acquir Immune Defic Syndr. 2020;84(5):437\u201342. https:\/\/doi.org\/10.1097\/qai.0000000000002403]. [PMID 32692101].","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"516_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/trgh.2016.0005]","volume":"1","author":"RA Crosby","year":"2016","unstructured":"Crosby RA, Salazar LF, Hill BJ. Gender affirmation and Resiliency among Black Transgender Women with and without HIV infection. Transgend Health. 2016;1(1):86\u201393doi. https:\/\/doi.org\/10.1089\/trgh.2016.0005]. [PMID 29159300].","journal-title":"Transgend Health"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00516-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-023-00516-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-023-00516-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T17:06:08Z","timestamp":1682096768000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-023-00516-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,21]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["516"],"URL":"https:\/\/doi.org\/10.1186\/s12981-023-00516-0","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,21]]},"assertion":[{"value":"24 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board at Ann & Robert H. Lurie Children\u2019s Hospital of Chicago with a waiver of parental permission for minors aged 17 years old. All participants were provided written consent prior to participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"24"}}